SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q2 2023
Institutional positions in SAB Biotherapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −1 vs. Q1 2023
- Shares held
- 3.96M
- +87.8K (+2.3%) vs. Q1 2023
- Total value
- $3.28M
- +$1.58M (+92.2%) vs. Q1 2023
- New holders
- 4
- 7 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GWM Advisors LLC | 145 | $120 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 247 | $205 | 0.00% | +60+32.1% | Added |
| Harbour Investments, Inc. | 500 | $415 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 881 | $731 | 0.00% | 00.0% | Unchanged |
| Gs Investments, Inc. | 2,000 | $1.66K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,368 | $4.00K | 0.00% | +548+11.4% | Added |
| Elgethun Capital Management | 9,935 | $8.25K | 0.00% | +2,894+41.1% | Added |
| 1st Source Bank | 10,000 | $8.30K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 10,000 | $8.30K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,865 | $10.7K | 0.00% | −574−4.3% | Reduced |
| Nadler Financial Group, Inc. | 13,750 | $11.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 14,545 | $12.1K | 0.00% | −1,517−9.4% | Reduced |
| Strategic Financial Concepts, LLC | 15,027 | $12.5K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 16,238 | $13.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,306 | $14.4K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 18,896 | $15.7K | 0.00% | −200−1.0% | Reduced |
| Kestra Advisory Services, LLC | 21,000 | $17.4K | 0.00% | +10,000+90.9% | Added |
| Brookstone Capital Management | 21,755 | $18.6K | 0.00% | 00.0% | Unchanged |
| LGL Partners, LLC | 23,000 | $19.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 25,094 | $20.8K | 0.00% | +25,094 | New |
| Virtu Financial LLC | 24,897 | $21.0K | 0.00% | +9,883+65.8% | Added |
| Prudential Financial Inc | 36,200 | $30.0K | 0.00% | +36,200 | New |
| Northern Trust Corp | 44,476 | $36.9K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 47,518 | $39.4K | 0.00% | 00.0% | Unchanged |
| Silver Oak Securities, Inc | 51,891 | $43.0K | 0.01% | 00.0% | Unchanged |
| Peapack Gladstone Financial Corp | 52,296 | $43.0K | 0.00% | +52,296 | New |
| BlackRock Inc. | 52,643 | $43.7K | 0.00% | −57,370−52.1% | Reduced |
| Renaissance Technologies LLC | 54,400 | $45.0K | 0.00% | +54,400 | New |
| Mariner, LLC | 69,000 | $57.3K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 73,470 | $61.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 81,241 | $67.4K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 84,000 | $69.7K | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 192,027 | $159.4K | 0.03% | +42,253+28.2% | Added |
| First Manhattan Co | 277,777 | $230.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 300,529 | $249.4K | 0.00% | 00.0% | Unchanged |
| Veritable, L.P. | 506,513 | $420.4K | 0.01% | 00.0% | Unchanged |
| First PREMIER Bank | 807,535 | $670.0K | 0.19% | 00.0% | Unchanged |
| Vanguard Group Inc | 962,738 | $799.1K | 0.00% | +261,154+37.2% | Added |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −177,659−100.0% | Sold out |
| Meteora Capital, LLC | 0 | $0 | 0.00% | −134,524−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,400−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,679−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |